Facebook Linkedin RSS Twitter Youtube
Home 2023

Genetic diseases

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease
Genome Editing

FDA Approves Casgevy, the First CRISPR Therapy, for Sickle Cell Disease

RoslinCT Will Manufacture World’s-First CRISPR-Based Therapy
Bioprocessing

RoslinCT Will Manufacture World’s-First CRISPR-Based Therapy

Decades of mRNA Research Come to Fruition
Coronavirus

Decades of mRNA Research Come to Fruition

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs
Genome Editing

“Transformer” Base Editor Safely and Durably Induces Fetal Hemoglobin in Human HSCs

StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover
GEN Edge

StockWatch: Verve Investors Accentuate the Negative as Shares Tumble, Then Recover

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease
Genome Editing

The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin
Drug Discovery

Gene Therapy Briefs: Activist Investor Reported to Take $1B Stake in BioMarin

NGS Updates from ASHG: What’s New in Sequencing?
Industry News

NGS Updates from ASHG: What’s New in Sequencing?

Quick Takes: Final Highlights from the 2023 ASHG Annual Meeting
Cancer

Quick Takes: Final Highlights from the 2023 ASHG Annual Meeting

At ASHG, Fabric Genomics Announces Software Deals with Oxford Nanopore, DNAnexus
Artificial Intelligence

At ASHG, Fabric Genomics Announces Software Deals with Oxford Nanopore, DNAnexus

123...78Page 1 of 78
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.